P1482: PATIENTS WITH SEVERE SICKLE CELL DISEASE ON STANDARD OF CARE TREATMENT ARE VERY UNLIKELY TO BECOME VOC FREE FOR ONE YEAR: A COHORT STUDY OF MEDICAID ENROLLEES
M. Mahesri,
S. B. Lee,
R. Levin,
S. Imren,
L. Zhang,
T. Beukelman,
L. Titievsky,
R. J. Desai
Affiliations
M. Mahesri
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital & Harvard Medical School
S. B. Lee
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital & Harvard Medical School
R. Levin
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital & Harvard Medical School
S. Imren
2 Vertex Pharmaceuticals, Boston, United States of America
L. Zhang
2 Vertex Pharmaceuticals, Boston, United States of America
T. Beukelman
2 Vertex Pharmaceuticals, Boston, United States of America
L. Titievsky
2 Vertex Pharmaceuticals, Boston, United States of America
R. J. Desai
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital & Harvard Medical School
